glp-1 receptor agonist pancreatitis risk meta-analysis Glucagon-Like Peptide-1 Agonists Use... : American Journal of Gastroenterology Glucagon-like peptide-1 (GLP-1) receptor agonists
Description
T2DM: type 2 diabetes mellitus Visceral pain and irritable bowel syndrome Irritable bowel syndrome (IBS) is primarily characterized by chronic abdominal pain or discomfort
This is not about choosing between medicine and food
Maya and colleagues reported that pregnancies exposed to GLP-1s had a greater risk for gestational weight gain (RR = 1.32
Pediatric Endocrine Society obesity special interest G
